Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis

被引：1
|
作者：
Casale, Thomas
Mesana, Laura
Pacou, Maud
Farge, GaeLle
Sun, Shawn X.
Castro, Mario
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.OA2903
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA2903
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis
    Casale, Thomas B.
    Pacou, Maud
    Mesana, Laura
    Farge, Gaelle
    Sun, Shawn X.
    Castro, Mario
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01): : 122 - +
  • [2] Comparative efficacy of biologics for patients with inadequately controlled asthma: A network meta-analysis
    Kim, Hayeon
    Kim, Myeong Gyu
    Kim, Sung-Ryeol
    Lee, Jae-Hyun
    Byun, Youngjoo
    Park, Jiwon
    Kim, Kyungim
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (07):
  • [3] Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils
    Brusselle, Guy
    Germinaro, Matthew
    Weiss, Sivan
    Zangrilli, James
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 43 : 39 - 45
  • [4] Effectiveness of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
    Akenroye, Ayobami
    Lassiter, Grace
    Jackson, John
    Keet, Corinne
    Segal, Jodi
    Alexander, Caleb
    Hong, Hwanhee
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB147 - AB147
  • [5] The efficacy and safety of reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: A systematic review and meta-analysis
    Li, Jinfeng
    Wang, Fangfang
    Lin, Cunzhi
    Du, Jianxin
    Xiao, Baohong
    Du, Chunhua
    Sun, Jiaxing
    [J]. JOURNAL OF ASTHMA, 2017, 54 (03) : 300 - 307
  • [6] LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
    Brusselle, Guy
    Germinaro, Matthew
    Eid, Sherrine
    Zangrilli, James
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
    Akenroye, Ayobami
    Lassiter, Grace
    Jackson, John W.
    Keet, Corinne
    Segal, Jodi
    Alexander, G. Caleb
    Hong, Hwanhee
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (05) : 1097 - +
  • [8] Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis
    Nopsopon, Tanawin
    Lassiter, Grace
    Chen, Ming-Li
    Alexander, Caleb
    Keet, Corinne
    Hong, Hwanhee
    Akenroye, Ayobami
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (03) : 747 - 755
  • [9] Tiotropium Versus Placebo for Inadequately Controlled Asthma: A Meta-Analysis
    Tian, Jing-wei
    Chen, Jin-wu
    Chen, Rui
    Chen, Xin
    [J]. RESPIRATORY CARE, 2014, 59 (05) : 654 - 666
  • [10] COMPARATIVE EFFICACY OF RESLIZUMAB AND MEPOLIZUMAB FOR THE TREATMENT OF ASTHMA: A NETWORK META-ANALYSIS
    Sharma, R.
    Cheung, A.
    Bolzani, A.
    Barakat, S.
    Sun, S. X.
    Tarasova, O.
    Druyts, E.
    FitzGerald, J. M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A549 - A549
12345